Business
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News
A study finds treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces…
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been…
-
Noosa News22 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News12 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General9 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News10 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test